Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells

Experimental Hematology

Volumn 33, Issue 12, 2005, Pages 1531-1536

  Ayuk, Francis A ^a   Fang, Lubin ^a   Fehse, Boris ^a   Zander, Axel R ^a   Kröger, Nicolaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINODACTINOMYCIN; ALEMTUZUMAB; CASPASE; CASPASE INHIBITOR; COMPLEMENT; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; THYMOCYTE ANTIBODY;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL DEATH; CELL KILLING; CELL STRAIN K 562; COMPLEMENT DEPENDENT CYTOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MYELOMA CELL; PRIORITY JOURNAL; STAINING;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; APOPTOSIS; BONE MARROW; CASPASES; CELL DEATH; COMPLEMENT SYSTEM PROTEINS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MULTIPLE MYELOMA; TRANSPLANTATION CONDITIONING; TUMOR CELLS, CULTURED;

EID: 28844482290     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.08.004     Document Type: Article

References (23)

1. B.B. Bjorkstrand, P. Ljungman, and H. Svensson Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation Blood 88 1996 4711 4718
2. G. Gahrton, H. Svensson, and M. Cavo European Group for Blood and Marrow Transplantation. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-8 at European Group for Blood and Marrow Transplantation centres Br J Haematol 113 2001 209 216
3. A. Badros, B. Barlogie, and C. Morris High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions Blood 97 2001 2574 2579
4. N. Kroger, H.G. Sayer, and R. Schwerdtfeger Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality Blood 100 2002 3919 3924
5. D.G. Maloney, A.J. Molina, and F. Sahebi Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma Blood 102 2003 3447 3454
6. K.S. Peggs, S. Mackinnon, and C.D. Williams Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity Biol Blood Marrow Transplant 9 2003 257 265
7. R. Chakraverty, K. Peggs, and R. Chopra Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen Blood 99 2002 1071 1078
8. N. Kroger, R. Schwerdtfeger, and M. Kiehl Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma Blood 100 2002 755 760
9. A. Nagler, M. Aker, and R. Or Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation Exp Hematol 29 2001 362 370
10. J.S. Crowe, V.S. Hall, M.A. Smith, H.J. Cooper, and J.P. Tite Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material Clin Exp Immunol 87 1992 105 110
11. N. Bonnefoy-Berard, and J.P. Revillard Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3 J Heart Lung Transplant 15 1996 435 442
12. M.J. Keating, I. Flinn, and V. Jain Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study Blood 99 2002 3554 3561
13. P. Lin, R. Owens, G. Tricot, and C.S. Wilson Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma Am J Clin Pathol 121 2004 482 488
14. N. Bonnefoy-Berard, L. Genestier, and M. Flacher Apoptosis induced by polyclonal antilymphocyte globulins in human B-cell lines Blood 83 1994 1051 1059
15. N. Kroger, B. Shaw, and S. Iacobelli Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma Br J Haematol 129 2005 631 643
16. C. Crawley, M. Lalancette, and R. Szydlo Outcomes for reduced intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the chronic leukemia working party of the EBMT Blood 105 2005 4532 4539 Epub 2005 Feb 24
17. T.H. Eiermann, P. Lambrecht, and A.R. Zander Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients Bone Marrow Transplant 23 1999 779 781
18. S. Giralt, P.F. Thall, and I. Khouri Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation Blood 97 2001 631 637
19. G. Hale, S. Cobbold, and N. Novitzky CAMPATH-1 antibodies in stem-cell transplantation Cytotherapy 3 2001 145 164
20. L. Fang, B. Fehse, M. Engel, A. Zander, and N. Kroger Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells Transplantation 2005 369 371
21. P. Klangsinsirikul, G.I. Carter, J.L. Byrne, G. Hale, and N.H. Russell Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution Blood 99 2002 2586 2591
22. M.C. Michallet, F. Saltel, X. Preville, M. Flacher, J.P. Revillard, and L. Genestier Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion Blood 2003 15;102:3719-3726. Epub 2003 Jul 31
23. E. Metchnikoff Etude sur la resorption des cellules Ann Inst Pasteur 13 1899 737